Birmingham, Ala. Nov. 16, 2020 – AI Metrics, LLC, a medical imaging startup focused on leveraging artificial intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the company’s LSN (Liver Surface Nodularity) module. This first FDA clearance represents a significant milestone for AI Metrics, where researchers have been seeking new ways to use CT scans for virtual liver biopsy.